Only an increase in sales & revenue will save this. More pain in the short term, but long term holders should not worry. IMO of course.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025